Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly;
sign up here. From a generic drug surge to European bond realities, here are four charts that tell you what you need to know in business today.
Iran may be grabbing headlines, but U.S. production trends are likely to have a bigger impact
on oil prices.
Data: Energy Information Administration; graphic by Bloomberg Gadfly
The growing trend of companies doing deals outside their wheelhouse may lead to an M&A
rebound in 2018.
Back to Reality?
Bond investors appear to have finally noticed the ECB's efforts to wean markets
from life support.
Rewrite the Record Book
Generic drug approvals have skyrocketed under new FDA chief Scott Gottlieb -- which will have a far-ranging and often negative impact
on the pharmaceutical industry.
And don't miss Gadfly's toast to those who left the business scene in 2017, including farewells to Travis Kalanick, Jeff Immelt, and Mickey Drexler.
This column does not necessarily reflect the opinion of Bloomberg LP and its owners.
To contact the editor responsible for this story:
at Mark Gongloff email@example.com